Target intelligence / Profile preview

Gastrointestinal smooth muscle receptors

Molecular classification
G protein-coupled receptor, Ion channel, Receptor
01

Overview

Gastrointestinal (GI) smooth muscle receptors are a diverse group of signaling proteins, primarily G protein-coupled receptors (GPCRs), that regulate the mechanical activity and motility of the digestive tract. These receptors are located on the plasma membrane of smooth muscle cells and respond to various neurotransmitters, hormones, and paracrine factors to modulate muscle tone and peristalsis [StatPearls: NBK526124]. Key excitatory receptors include the muscarinic M3 and M2 receptors, which respond to acetylcholine to trigger contraction, and the motilin receptor, which initiates migrating motor complexes [PubMed: 11588143]. Conversely, inhibitory signaling is often mediated by adrenergic receptors and receptors for vasoactive intestinal peptide (VIP), which promote relaxation [PMC3143511]. Serotonin receptors, particularly 5-HT3 and 5-HT4, also play critical roles in modulating the peristaltic reflex and visceral sensation. Clinical conditions such as irritable bowel syndrome (IBS), gastroparesis, and chronic constipation often involve the dysfunction of these receptor-mediated pathways. Pharmacological interventions target these receptors using agonists or antagonists to normalize GI transit, though achieving organ-specific effects remains a challenge to minimize systemic adverse reactions [PubChem].

Other names
Gut smooth muscle receptorsEnteric smooth muscle receptorsGI tract smooth muscle receptors
02

Mechanism of action

Modulation of smooth muscle tone through agonism or antagonism of various G protein-coupled receptors, leading to changes in intracellular calcium concentration and the phosphorylation state of myosin light chains to either stimulate or inhibit contraction.

03

Biological functions

Signal transductionMuscle contractionMuscle relaxationPeristalsisGastric emptying
04

Disease associations

Irritable bowel syndromeGastroparesisGastroesophageal reflux diseaseConstipationDiarrheaChronic intestinal pseudo-obstruction
05

Safety considerations

Systemic anticholinergic toxicityCardiovascular arrhythmias (e.g., QT prolongation)Ischemic colitisCentral nervous system depressionTachyphylaxis
06

Interacting drugs

Atropine

7 more in the full profile.

07

Biomarkers

Gastric emptying rateColonic transit timeIntraluminal pressure (manometry)Wireless motility capsule transit time

Beyond the preview

Go deeper on Gastrointestinal smooth muscle receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal smooth muscle receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call